Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Moyer Farms Making $12M Investment
Niagara Falls Going Green for St. Patrick's Day
St. Catharines RIDE Campaign
Davies Challenges Gov't on EV Support
Welland's Plan for Hospital Contribution
New GO Station Coming to Niagara
Most Serious Collisions in Summer: Region
Coach Service Added to Airport